Home›Research›Compare›KPV vs LL-37
Peptide ComparisonKPV vs LL-37
Both are Tissue Repair peptides.
KPV
Lys-Pro-Val
Half-life: Short (minutes to hours)
102 providers listed
LL-37 carries stronger published evidence (Cohort study, 19 key studies) than KPV (Cohort study, 6); both are research compounds.
KPV
Evidence
Half-life
Short (minutes to hours)
LL-37
Evidence
Half-life
~30 minutes
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | LL-37 |
| Oral administration option | KPV |
| Lower typical price per mg | KPV |
| More provider options (102 vs 38) | KPV |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
KPV
LL-37
KPV
Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the P…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
+2 more
LL-37
Immunomodulatory effects of synthetic antimicrobial peptides on LPS-induced inflammatory responses in THP-1 m…
The Role of Vitamin D in Modulating the Innate Immune Response in Children with Vesicoureteral Reflux.
Antimicrobial peptoids pass rapidly through bacterial membranes and flocculate ribosomes and DNA: A single-ce…
Antimicrobial peptoids pass rapidly through bacterial membranes and flocculate ribosomes and DNA: A single-ce…
+15 more
About KPV
Derived from alpha-MSH; binds melanocortin receptors MC1R/MC3R to suppress NF-κB and inflammatory cytokines
About LL-37
Human cathelicidin antimicrobial peptide; disrupts bacterial membranes and modulates innate immune response via TLR signaling
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
KPV
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
LL-37
No established clinical contraindications
KPV
LL-37
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Tissue Repair Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). KPV vs LL-37 — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/kpv/ll-37